Actively Recruiting
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
Led by Mayo Clinic · Updated on 2026-02-23
154
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).
CONDITIONS
Official Title
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester
- Age 18 years or older
- Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC
- Patient has given permission to provide blood and saliva samples for research testing
- Ability to complete questionnaires by themselves or with assistance
You will not qualify if you...
- HPV-negative OPSCC
- Unable to provide informed consent
- Unwilling to attend screening visit at Mayo Clinic site if indicated
- Unwilling or unable to complete surveys electronically
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here